Related Experiment Videos
Nuclear and echocardiographic imaging for prediction of reversible left ventricular ischemic dysfunction after
J L Vanoverschelde1, B Gerber, A Pasquet
1Division of Cardiology, University of Louvain Medical School, Brussels, Belgium.
Insights
Predicting recovery of heart function after revascularization is key. Current methods like thallium imaging and dobutamine echocardiography show high sensitivity, with dobutamine echocardiography offering better specificity for identifying viable myocardium.
Area of Science:
- Cardiology
- Medical Imaging
- Cardiovascular Disease
Background:
- Modern coronary artery disease (CAD) therapy focuses on revascularization to restore blood flow to ischemic areas.
- Interventional strategies like bypass surgery and angioplasty have reduced mortality from acute myocardial infarction and chronic CAD.
- Revascularization benefits are thought to stem from improved blood supply to dysfunctional but viable myocardium, enhancing left ventricular function.
Purpose of the Study:
- To review methods for predicting the reversibility of left ventricular dysfunction after coronary revascularization.
- To assess the sensitivity and specificity of current imaging modalities in identifying jeopardized but viable myocardium.
Main Methods:
- Evaluation of cellular mechanisms crucial for systolic function recovery post-revascularization.
- Analysis of established imaging techniques: thallium imaging, positron emission tomography, and low-dose dobutamine echocardiography.
- Consideration of emerging modalities like FDG/MIBI SPECT, contrast echocardiography, and integrated backscatter imaging.
Main Results:
- Current modalities achieve high sensitivity (>80%) in predicting reversible dysfunction.
- Specificity varies: thallium imaging (50-55%), positron emission tomography (not specified), and dobutamine echocardiography (80-85%).
- Newer techniques show promise for enhanced identification of viable myocardium.
Conclusions:
- Accurate prediction of myocardial viability is essential for guiding revascularization therapy in coronary artery disease.
- Dobutamine echocardiography demonstrates superior specificity among currently widely used methods.
- Advancements in imaging technology are expected to further improve the ability to identify at-risk but salvageable heart muscle.
Abstract:
Modern therapy of coronary artery disease (CAD) increasingly involves interventional strategies aimed at restoring blood flow to the ischemic myocardium. The emergence of coronary artery bypass surgery, percutaneous transluminal coronary angioplasty, and more recently thrombolytic therapy, has helped to change the natural course of ischemic heart disease and contribute to the overall reduction in the mortality from both acute myocardial infarction and chronic CAD. Presumably, the beneficial effects of revascularization result from improving blood supply to dysfunctional but viable regions with subsequent improvement in regional and global left ventricular function. Over the past decade, several approaches have been proposed to predict the reversibility of left ventricular dysfunction after coronary revascularization. For the most part, these methods rely on assessment of basic cellular mechanisms that are known to play a central role in the recovery of systolic function after coronary revascularization. These include sufficient resting perfusion to provide metabolic fuels and to allow wash-out of toxic metabolites, maintain membrane integrity (which includes the ability to generate transmembrane ionic gradients and to transport energy providing substrates), preserve metabolic machinery (to allow glucose, fatty acid and oxygen consumption), and recruitable inotropic reserve. Among the available modalities, thallium imaging, positron emission tomography, and low-dose dobutamine echocardiography are currently the most frequently used in the clinical setting. All allow prediction of reversible dysfunction with a high degree of sensitivity (greater than 80%). They seem to vary, however, in terms of specificity, thallium imaging showing the lowest (50-55%) and dobutamine echocardiography the highest (80-85%) specificity. New promising modalities, such as FDG or MIBI SPECT imaging, contrast echocardiography and integrated backscatter imaging are just ahead and will likely strengthen further our ability to identify jeopardized but viable myocardium.